A méh leiomyomája

Translated title of the contribution: Uterine leiomyoma

Éva Csatlós, J. Rigó, I. Szabó, Zsolt Nagy, József Gábor Joó

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Uterine fibroids, benign tumors of the human uterus, are the most common indication for hysterectomy. They are clinically apparent in 20-25% of women and cause significant complaints, like prolonged and heavy menstruation, pelvic pressure or pain, sometimes reproductive dysfunction. Though surgery has been the mainstay of fibroid treatment, various minimally invasive procedures have been developed in addition to hysterectomy and abdominal myomectomy. Formation of new leiomyomas after these conservative therapies remains a substantial problem. Also drug-therapy methods are available, but the possible side-effects limit their long-term use. Authors attempt to give an overview of this common gynecological disease, yielding a new insight into the basic biology and genetics of fibroids, with the hope of new and effective methods of therapy in the future.

Original languageHungarian
Pages (from-to)1734-1741
Number of pages8
JournalOrvosi Hetilap
Volume151
Issue number42
DOIs
Publication statusPublished - Oct 1 2010

Fingerprint

Leiomyoma
Hysterectomy
Uterine Myomectomy
Menstruation
Uterus
Pressure
Drug Therapy
Pain
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Csatlós, É., Rigó, J., Szabó, I., Nagy, Z., & Joó, J. G. (2010). A méh leiomyomája. Orvosi Hetilap, 151(42), 1734-1741. https://doi.org/10.1556/OH.2010.28977

A méh leiomyomája. / Csatlós, Éva; Rigó, J.; Szabó, I.; Nagy, Zsolt; Joó, József Gábor.

In: Orvosi Hetilap, Vol. 151, No. 42, 01.10.2010, p. 1734-1741.

Research output: Contribution to journalArticle

Csatlós, É, Rigó, J, Szabó, I, Nagy, Z & Joó, JG 2010, 'A méh leiomyomája', Orvosi Hetilap, vol. 151, no. 42, pp. 1734-1741. https://doi.org/10.1556/OH.2010.28977
Csatlós É, Rigó J, Szabó I, Nagy Z, Joó JG. A méh leiomyomája. Orvosi Hetilap. 2010 Oct 1;151(42):1734-1741. https://doi.org/10.1556/OH.2010.28977
Csatlós, Éva ; Rigó, J. ; Szabó, I. ; Nagy, Zsolt ; Joó, József Gábor. / A méh leiomyomája. In: Orvosi Hetilap. 2010 ; Vol. 151, No. 42. pp. 1734-1741.
@article{9ca11f41852b41c9a9538148af59e4a1,
title = "A m{\'e}h leiomyom{\'a}ja",
abstract = "Uterine fibroids, benign tumors of the human uterus, are the most common indication for hysterectomy. They are clinically apparent in 20-25{\%} of women and cause significant complaints, like prolonged and heavy menstruation, pelvic pressure or pain, sometimes reproductive dysfunction. Though surgery has been the mainstay of fibroid treatment, various minimally invasive procedures have been developed in addition to hysterectomy and abdominal myomectomy. Formation of new leiomyomas after these conservative therapies remains a substantial problem. Also drug-therapy methods are available, but the possible side-effects limit their long-term use. Authors attempt to give an overview of this common gynecological disease, yielding a new insight into the basic biology and genetics of fibroids, with the hope of new and effective methods of therapy in the future.",
keywords = "hysterectomy, laparoscopic uterine artery occlusion (LUAO), MRI-guided focused ultrasound (MRgFUS), myolysis, myomectomy, ultrasound diagnostics, uterine artery embolisation (UAE), uterine leiomyoma",
author = "{\'E}va Csatl{\'o}s and J. Rig{\'o} and I. Szab{\'o} and Zsolt Nagy and Jo{\'o}, {J{\'o}zsef G{\'a}bor}",
year = "2010",
month = "10",
day = "1",
doi = "10.1556/OH.2010.28977",
language = "Hungarian",
volume = "151",
pages = "1734--1741",
journal = "Orvosi Hetilap",
issn = "0030-6002",
publisher = "Akademiai Kiado",
number = "42",

}

TY - JOUR

T1 - A méh leiomyomája

AU - Csatlós, Éva

AU - Rigó, J.

AU - Szabó, I.

AU - Nagy, Zsolt

AU - Joó, József Gábor

PY - 2010/10/1

Y1 - 2010/10/1

N2 - Uterine fibroids, benign tumors of the human uterus, are the most common indication for hysterectomy. They are clinically apparent in 20-25% of women and cause significant complaints, like prolonged and heavy menstruation, pelvic pressure or pain, sometimes reproductive dysfunction. Though surgery has been the mainstay of fibroid treatment, various minimally invasive procedures have been developed in addition to hysterectomy and abdominal myomectomy. Formation of new leiomyomas after these conservative therapies remains a substantial problem. Also drug-therapy methods are available, but the possible side-effects limit their long-term use. Authors attempt to give an overview of this common gynecological disease, yielding a new insight into the basic biology and genetics of fibroids, with the hope of new and effective methods of therapy in the future.

AB - Uterine fibroids, benign tumors of the human uterus, are the most common indication for hysterectomy. They are clinically apparent in 20-25% of women and cause significant complaints, like prolonged and heavy menstruation, pelvic pressure or pain, sometimes reproductive dysfunction. Though surgery has been the mainstay of fibroid treatment, various minimally invasive procedures have been developed in addition to hysterectomy and abdominal myomectomy. Formation of new leiomyomas after these conservative therapies remains a substantial problem. Also drug-therapy methods are available, but the possible side-effects limit their long-term use. Authors attempt to give an overview of this common gynecological disease, yielding a new insight into the basic biology and genetics of fibroids, with the hope of new and effective methods of therapy in the future.

KW - hysterectomy

KW - laparoscopic uterine artery occlusion (LUAO)

KW - MRI-guided focused ultrasound (MRgFUS)

KW - myolysis

KW - myomectomy

KW - ultrasound diagnostics

KW - uterine artery embolisation (UAE)

KW - uterine leiomyoma

UR - http://www.scopus.com/inward/record.url?scp=77957727056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77957727056&partnerID=8YFLogxK

U2 - 10.1556/OH.2010.28977

DO - 10.1556/OH.2010.28977

M3 - Article

C2 - 20889441

AN - SCOPUS:77957727056

VL - 151

SP - 1734

EP - 1741

JO - Orvosi Hetilap

JF - Orvosi Hetilap

SN - 0030-6002

IS - 42

ER -